3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Breast Neoplasms
17
Neoplasm Metastasis
8
Carcinoma, Non-Small-Cell Lung
6
Glioblastoma
5
Triple Negative Breast Neoplasms
4
Lymphoma, Mantle-Cell
4
Lymphoma, Follicular
4
Colorectal Neoplasms
4
Recurrence
3
Pancreatic Neoplasms
3
Ovarian Neoplasms
3
Neoplasms
3
Lymphoma, Large B-Cell, Diffuse
3
Squamous Cell Carcinoma of Head and Neck
2
Solid Tumors
2
Lymphoma
2
Lung Neoplasms
2
Leukemia, Myeloid, Acute
2
Hereditary Sensory and Autonomic Neuropathies
2
Head and Neck Neoplasms
2
Endometrial Neoplasms
2
Brain Neoplasms
2
Waldenstrom Macroglobulinemia
1
Unspecified Adult Solid Tumor, Protocol Specific
1
Tongue Neoplasms
1
Thymoma
1
Stomach Neoplasms
1
Salivary Gland Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pre-menopausal Breast Cancer
1
Interventions
3-fluoro-2-(4-((2-nitro-1H-imidazol-1-yl)methyl)-1H-1,2,3-triazol-1-yl)propan-1-ol
4
pimonidazole
2
TH 302
2
gadobutrol
1
fluoromisonidazole
1
Surgical Procedures, Operative
1
Sodium Chloride
1
Sevoflurane
1
Saline Solution
1
Radiotherapy
1
Propofol
1
Positron Emission Tomography Computed Tomography
1
Pancreaticoduodenectomy
1
Oxygen
1
NVP-BKM120
1
Ketamine
1
Gemcitabine
1
Ferrosoferric Oxide
1
Dexmedetomidine
1
Blood Specimen Collection
1
Biopsy
1
Bacterial Load
1
Atovaquone
1
3-(4-(2-fluoroethoxy)phenyl)-2-(3-methyl-2-(4-((2-sulfamoylbenzo(d)thiazol-6-yloxy)methyl)-1H-1,2,3-triazol-1-yl)butanamido)propanoic acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Hypoxia
×
NVP-BKM120
×
Clear all
NCT02128724
2019-08-01
BKM120
University of Oxford
Phase 1
Completed
21 enrolled
23 charts